ArticleCancer management and research2020

Inhibition of lncRNA PART1 Chemosensitizes Wild Type but Not KRAS Mutant NSCLC Cells.

Shu-Chen Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.